Articles dans des revues avec comité de lecture (263)
  1. 85. Martelli, A., Friedman, L. S., Reutenauer, L., Messaddeq, N., Perlman, S. L., Lynch, D. R., Fedosov, K., Schulz, J. B., Pandolfo, M., & Puccio, H. (2012). Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia. Disease Models and Mechanisms. doi:10.1242/dmm.009829
  2. 86. Stein, J. L., Pandolfo, M., Depondt, C., et al. (2012). Identification of common variants associated with human hippocampal and intracranial volumes. Nature genetics, 44, 552–561. doi:10.1038/ng.2250
  3. 87. Dedobbeleer, C., Rai, M., Donal, E., Pandolfo, M., & Unger, P. (2012). Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich's ataxia. European heart journal. Cardiovascular imaging, 13(4), 346-352. doi:10.1093/ejechocard/jer267
  4. 88. McCormack, M., Urban, T. J., Shianna, K. V., Walley, N., Pandolfo, M., Depondt, C., Chaila, E., O'Conner, G. D., Kasperavičiūtė, D., Radtke, R. A., Heinzen, E., Sisodiya, S. M., Delanty, N., & Cavalleri, G. L. (2012). Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions. Pharmacogenomics, 13(4), 399-405. doi:10.2217/pgs.11.165
  5. 89. Kearney, M., Orrell, R. W., Fahey, M., & Pandolfo, M. (2012). Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane database of systematic reviews (Online), 4, CD007791. doi:10.1002/14651858.CD007791.pub3
  6. 90. Traylor, M., Abboud, S., Pandolfo, M., et al. (2012). Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet neurology, 11(11), 951-962.
  7. 91. Chintawar, S., Fregnan, F., Pandolfo, M., & Geuna, S. (2012). Stereological quantification of Cerebellar Purkinje cells: Literature review and description of a variation of the physical disector method adapted to confocal laser microscopy. NeuroQuantology, 10(1), 125-131.
  8. 92. Cnop, M., Igoillo Esteve, M., Rai, M., Begu, A., Serroukh, Y., Depondt, C., Musuaya, A., Marhfour, I., Ladrière, L., Moles Lopez, X., Lefkaditis, D., Moore, F., Brion, J. P., Cooper, M. J., Schapira, A. H., Clark, A., Koeppen, A., Marchetti, P., Pandolfo, M., Eizirik, D. L., & Fery, F. (2012). Central role and mechanisms of beta-cell dysfunction and death in Friedreich ataxia- associated diabetes. Annals of neurology, 72(6), 971-982. doi:10.1002/ana.23698
  9. 93. Coppola, G., Burnett, R., Perlman, S. L., Versano, R., Gao, F., Plasterer, H., Rai, M., Saccá, F., Filla, A., Lynch, D. R., Rusche, J. R., Gottesfeld, J. M., Pandolfo, M., & Geschwind, D. H. (2011). A gene expression phenotype in lymphocytes from Friedreich ataxia patients. Annals of neurology, 70(5), 790-804. doi:10.1002/ana.22526
  10. 94. Pandolfo, M. (2011). Genetics of epilepsy. Seminars in neurology, 31(5), 506-518. doi:10.1055/s-0031-1299789
  11. 95. Rahman, F., & Pandolfo, M. (2011). Cardiomyopathy in Friedreich's ataxia. Acta neurologica belgica, 111(3), 183-187.
  12. 96. Depondt, C., Godard, P., Sens Espel, R., Lopes Da Cruz, A., Lienard, P., & Pandolfo, M. (2011). A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxicity. European journal of neurology, 18(9), 1159-1164. doi:10.1111/j.1468-1331.2011.03361.x
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Suivant >>